In human prostate carcinoma, it was demonstrated that TRPM8 channel activation with TRPM8 agonists promotes apoptosis, an effect mediated by an increase in intracellular Ca2+ concentration (Zhang and Barritt, 2004; Alaimo et al., 2020). This evidence concerns the gene TRPM8 and prostate carcinoma.